SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition

Selenium-binding protein 1 (SELENBP1) is frequently dysregulated in various malignancies including colorectal cancer (CRC); however, its roles in progression of CRCs and the underlying mechanism remain to be elucidated. In this study, we compared the expression of SELENBP1 between CRCs and colorecta...

Full description

Bibliographic Details
Main Authors: Zhang Xiaotian, Hong Runqi, Bei Lanxin, Hu Zhiqing, Yang Ximin, Song Tao, Chen Liang, Meng He, Niu Gengming, Ke Chongwei
Format: Article
Language:English
Published: De Gruyter 2022-09-01
Series:Open Medicine
Subjects:
selenium-binding protein 1
colorectal cancer
progression
tumorigenesis
epithelial–mesenchymal transition
Online Access:https://doi.org/10.1515/med-2022-0532

Internet

https://doi.org/10.1515/med-2022-0532

Similar Items